Convergence: FDA official reviews common BLA deficiencies, offers advice on avoiding CRLs
Regulatory NewsJoanne S. Eglovitch
Approval/marketing authorizationBiologics/ biosimilars/ vaccinesCDERProduct LifecycleSubmission and registrationUnited StatesUS Food and Drug Administration (FDA)